Cargando…
Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression
Lung disease in cystic fibrosis (CF) starts early, with studies identifying abnormalities on chest computed tomography (CT) scan even in infancy. In this retrospective study, abnormal chest CT was the main outcome; body mass index (BMI) z score and forced expiratory volume percent predicted (FEV(1)%...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682578/ https://www.ncbi.nlm.nih.gov/pubmed/29164174 http://dx.doi.org/10.1177/2333794X17738465 |
_version_ | 1783278122966188032 |
---|---|
author | Petrocheilou, Argyri Papagrigoriou-Theodoridou, Maria Michos, Athanasios Doudounakis, Stavros-Eleftherios Loukou, Ioanna Kaditis, Athanasios |
author_facet | Petrocheilou, Argyri Papagrigoriou-Theodoridou, Maria Michos, Athanasios Doudounakis, Stavros-Eleftherios Loukou, Ioanna Kaditis, Athanasios |
author_sort | Petrocheilou, Argyri |
collection | PubMed |
description | Lung disease in cystic fibrosis (CF) starts early, with studies identifying abnormalities on chest computed tomography (CT) scan even in infancy. In this retrospective study, abnormal chest CT was the main outcome; body mass index (BMI) z score and forced expiratory volume percent predicted (FEV(1)%) predicted at age 6 to 7 years were secondary outcomes. Pseudomonas aeruginosa infection prior to 12 months of age was the main explanatory variable. There was no association between early P aeruginosa infection and abnormal CT after adjustment for CFTR (cystic fibrosis transmembrane conductance regulator) functional mutation class, gender, and other pathogens (odds ratio = 0.30; 95% confidence interval = 0.07-1.35; P = .11). No significant associations were demonstrated for BMI z score and FEV(1)% predicted. Children with class I-III CFTR mutations had increased risk of abnormal CT findings (odds ratio = 11.67; 95% confidence interval = 1.11-115.06; P = .035) and lower FEV(1)% predicted (P = .04). In the current era, early-life P aeruginosa infection in CF might not influence the severity of lung disease in school age as much as previously. Larger studies are needed to confirm this finding. |
format | Online Article Text |
id | pubmed-5682578 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-56825782017-11-21 Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression Petrocheilou, Argyri Papagrigoriou-Theodoridou, Maria Michos, Athanasios Doudounakis, Stavros-Eleftherios Loukou, Ioanna Kaditis, Athanasios Glob Pediatr Health Original Article Lung disease in cystic fibrosis (CF) starts early, with studies identifying abnormalities on chest computed tomography (CT) scan even in infancy. In this retrospective study, abnormal chest CT was the main outcome; body mass index (BMI) z score and forced expiratory volume percent predicted (FEV(1)%) predicted at age 6 to 7 years were secondary outcomes. Pseudomonas aeruginosa infection prior to 12 months of age was the main explanatory variable. There was no association between early P aeruginosa infection and abnormal CT after adjustment for CFTR (cystic fibrosis transmembrane conductance regulator) functional mutation class, gender, and other pathogens (odds ratio = 0.30; 95% confidence interval = 0.07-1.35; P = .11). No significant associations were demonstrated for BMI z score and FEV(1)% predicted. Children with class I-III CFTR mutations had increased risk of abnormal CT findings (odds ratio = 11.67; 95% confidence interval = 1.11-115.06; P = .035) and lower FEV(1)% predicted (P = .04). In the current era, early-life P aeruginosa infection in CF might not influence the severity of lung disease in school age as much as previously. Larger studies are needed to confirm this finding. SAGE Publications 2017-11-08 /pmc/articles/PMC5682578/ /pubmed/29164174 http://dx.doi.org/10.1177/2333794X17738465 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Petrocheilou, Argyri Papagrigoriou-Theodoridou, Maria Michos, Athanasios Doudounakis, Stavros-Eleftherios Loukou, Ioanna Kaditis, Athanasios Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression |
title | Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression |
title_full | Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression |
title_fullStr | Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression |
title_full_unstemmed | Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression |
title_short | Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression |
title_sort | early-life pseudomonas aeruginosa infection in cystic fibrosis and lung disease progression |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682578/ https://www.ncbi.nlm.nih.gov/pubmed/29164174 http://dx.doi.org/10.1177/2333794X17738465 |
work_keys_str_mv | AT petrocheilouargyri earlylifepseudomonasaeruginosainfectionincysticfibrosisandlungdiseaseprogression AT papagrigorioutheodoridoumaria earlylifepseudomonasaeruginosainfectionincysticfibrosisandlungdiseaseprogression AT michosathanasios earlylifepseudomonasaeruginosainfectionincysticfibrosisandlungdiseaseprogression AT doudounakisstavroseleftherios earlylifepseudomonasaeruginosainfectionincysticfibrosisandlungdiseaseprogression AT loukouioanna earlylifepseudomonasaeruginosainfectionincysticfibrosisandlungdiseaseprogression AT kaditisathanasios earlylifepseudomonasaeruginosainfectionincysticfibrosisandlungdiseaseprogression |